In August 2023, Zhongjing Wanxi Pharmaceutical Co., Ltd. strategically planned the establishment of Hong Kong Zhang Zhongjing Group Limited from a developmental standpoint. The company actively integrates into the national “Belt and Road” development framework and responds to the national strategy of promoting traditional Chinese medicine (TCM) “going global.” Hong Kong Zhang Zhongjing Group Limited is located in the business district of Cheung Sha Wan, HK, near the MTR Lai Chi Kok Station, at 888 Lai Chi Kok Road, NCB Innovation Centre which houses financial institutions, higher education institutions, listed companies, and other professional service organizations.

Zhongjing Wanxi Pharmaceutical Co., Ltd., established in 1978, is located in Nanyang, Henan Province, the hometown of medical sage Zhang Zhongjing. The company is one of the top 100 companies in Henan Province and among the top 50 TCM companies in China. Currently, it owns two A-share listed companies and two China Well-known Trademarks: “Yuyueshu” and “Zhongjing”. And Zhongjing has been awarded the title of “China Time-honored Brand” by the Ministry of Commerce. With TCM manufacturing as its core, the group has explored and formed a full-chain TCM cultivation model empowered by “technology + quality + brand + channels,” establishing the largest local pharmaceutical retail chain in Henan —Zhang Zhongjing Pharmacy, the largest production base for TCM concentrated pills in China, and a Seven-sphere Integrated Health Industry Chain consisting of Zhongjing Agriculture, Zhongjing Industry, Zhongjing Commerce, Zhongjing Food, Zhongjing Medicine, Zhongjing Health, and Hygienic Materials.

As the “bridgehead” of group’s internationalization strategy, Hong Kong Zhang Zhongjing Group Limited leverages the group’s industrial and brand advantages to build overseas trade, investment, and promotion platforms for the group. It establishes an overseas trade platform: implementing the “going global” strategy centered around the core products and businesses of Zhongjing Wanxi Pharmaceutical Co., Ltd.; Overseas investment platform: carrying out investment and financing activities based on the industrial layout of the group; Overseas brand promotion platform: promoting the internationalization of the Zhongjing culture and brand. The company capitalizes on Hong Kong’s advantage as an international financial center and innovation hub, utilizing the vibrant commercial environment and abundant innovation resources to optimize the allocation of global resources, enhancing the influence and competitiveness of the group and Zhongjing brand in the international market. Through continuous strategic layout, it deepens its global presence, laying a solid foundation for higher-level international development.

Hong Kong Zhang Zhongjing Group Limited mainly operates core products of Zhongjing Wanxi, including TCM, formula granules, refined herbs, classic herbal pastes, health foods, and hygienic products such as sanitary pads. The group consistently adheres to the concept “Herbs are great, herbs are healthy,” ensuring stable and reliable product quality from the source. It establishes standardized bases and constructs a large-scale, fully standardized production system to ensure that products are safe, reliable, and effective.

The company is a national high-tech enterprise with an independent R & D center and more than 30 full-time R & D technicians. It has in-depth cooperation with many domestic agricultural and pharmaceutical colleges, such as Lafat of Hungary, South Korea Natural Biology, China Agricultural University, Beijing University of traditional Chinese Medicine and so on.